Osaühing TüdrukudRegistered
Annual report for 2025 not filed.
Key figures
4 705 194 €−25,2%
Revenue 2024
+8,5%
Average annual growth 2019–2024
Ratios
202411,8%
Profit margin
14,7%
EBITDA margin
89,6%
Equity ratio
2,1×
Current ratio
17,1%
Return on equity
1149 €
Average gross salary
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q2 2026 | 1 238 146 € | 65 | 107 313 € |
| Q1 2026 | 1 080 559 € | 65 | 110 281 € |
| Q4 2025 | 1 168 933 € | 62 | 123 101 € |
| Q3 2025 | 924 904 € | 63 | 124 417 € |
| Q2 2025 | 1 280 687 € | 66 | 105 049 € |
| Q1 2025 | 1 181 225 € | 63 | 107 251 € |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Dividends
calculated2024
Distributed as dividends 80 000 € (3% of distributable profit).
History
202480 000 €
20230 €
20220 €
20210 €
20200 €
Previous year's retained earnings + previous year's profit − current retained earnings.
Summary of financial statements2019–2024
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Balance sheet — assets | ||||||
| Total current assets | 234 171 | 185 075 | 236 896 | 352 025 | 985 312 | 807 523 |
| Total non-current assets | 754 215 | 1 220 647 | 1 354 497 | 1 568 643 | 2 155 338 | 2 801 805 |
| Total assets | 988 386 | 1 405 722 | 1 591 393 | 1 920 668 | 3 140 650 | 3 609 328 |
| Balance sheet — liabilities and equity | ||||||
| Current liabilities | 220 947 | 271 871 | 348 519 | 384 640 | 382 348 | 377 071 |
| Non-current liabilities | 0 | 144 583 | 99 846 | 53 072 | 0 | — |
| Total liabilities | 220 947 | 416 454 | 448 365 | 437 712 | 382 348 | 377 071 |
| Share capital | 2556 | 2556 | 2556 | 2556 | 2556 | 2556 |
| Retained earnings of previous periods | 514 559 | 764 627 | 986 456 | 1 140 216 | 1 480 144 | 2 675 490 |
| Profit for the year | 250 068 | 221 829 | 153 760 | 339 928 | 1 275 346 | 553 955 |
| Reserves and other equity | 256 | 256 | 256 | 256 | 256 | 256 |
| Total equity | 767 439 | 989 268 | 1 143 028 | 1 482 956 | 2 758 302 | 3 232 257 |
| Income statement | ||||||
| Sales revenue | 3 124 298 | 2 968 233 | 2 995 338 | 3 443 176 | 6 291 195 | 4 705 194 |
| Operating profit | 251 876 | 231 016 | 164 129 | 349 495 | 1 281 645 | 573 637 |
| EBITDA | 300 168 | 277 861 | 209 544 | 395 351 | 1 346 259 | 691 423 |
| Profit before income tax | 250 068 | 221 829 | 153 760 | 339 928 | 1 275 346 | 573 955 |
| Profit for the reporting year | 250 068 | 221 829 | 153 760 | 339 928 | 1 275 346 | 553 955 |
| Labour costs | 560 154 | 506 388 | 639 450 | 634 880 | 1 233 994 | 1 142 942 |
| Depreciation of non-current assets | 48 292 | 46 845 | 45 415 | 45 856 | 64 614 | 117 786 |
| Other indicators | ||||||
| Employees | 53 | 52 | 50 | 52 | 58 | 59 |
| Calculated dividend | — | 0 | 0 | 0 | 0 | 80 000 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
CompanyPersonShareholderOther roleAdditional link
Annual reportsPDF, XBRL
Loading list of reports…
Source: e-Business Register (RIK). Files open/download directly from the official register.
Related companies
Same activity — Lepinguline toitlustusteenus jm toitlustamine